| XENON PHARMACEUTICALS |
| Kanada |
| Gesundheit |
| CA98420N1050 / A12ETN |
| XP0 (Frankfurt) / XENE (NASDAQ) |
| FRA:XP0, ETR:XP0, XP0:GR, NASDAQ:XENE |
| - |
| https://www.xenon-pharma... |
|
Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutics for patients with neurological and psychiatric dis..
>Volltext.. |
| 3010.9 Mio. EUR |
| 2550.71 Mio. EUR |
| 6.46 Mio. EUR |
| -318.92 Mio. EUR |
| -297.73 Mio. EUR |
| -3.75 EUR |
| 6.84 Mio. EUR |
| 171.42 Mio. EUR |
| -240.74 Mio. EUR |
| 13.13 |
| - |
| -30.11% |
| - |
| - |
| - |
| - |
| XENON PHARMACEUTICALS, XENON PHARMACEUTICAL, XENON PHARMA |
| 09.03.26 |